AU2018386657A1 — Auto injector for oxygen reduced packaging
Assigned to Inject Pharma Sweden AB · Expires 2020-07-02 · 6y expired
What this patent protects
The present invention relates to an auto injector (1) comprising a prefilled liquid medicament container, a hollow auto injector body (2) housing the medicament container. The auto injector body (2) has an elongated part, a first end side (21) and a second end side (22) and at le…
USPTO Abstract
The present invention relates to an auto injector (1) comprising a prefilled liquid medicament container, a hollow auto injector body (2) housing the medicament container. The auto injector body (2) has an elongated part, a first end side (21) and a second end side (22) and at least one through hole (3) arranged between the end sides (21, 22).The through holes (3) allow for flow of gas through the auto injector body (2) when the auto injector body (2) houses the medicament container. The invention further relates to a method comprising inserting the auto injector (1) into the package via an opening in a non-inert environment, and, in a non- inert environment and under atmospheric pressure: replacing the air in the package with inert atmosphere by one or several cycles of removing air and inserting inert gas through the opening, wherein the air and inert gas in part flows through the at least one through hole (3) of the auto injector (1). The method further comprises sealing the opening under vacuum.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.